Table 1 Protein expression levels of SREBP-2 in NSCLC and corresponding pericarcinous lung tissues.
From: SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancer
Tissue sample | No. of patients | SREBP-2 | p-value | |
---|---|---|---|---|
Low (%) | High (%) | |||
NSCLC | 263 | 165 (62.7) | 98 (37.3) | < 0.001a |
Peri-cancer | 263 | 259 (98.5) | 4 (1.5) | Â |